Literature DB >> 31474700

Fluctuations in antibody titers against enterovirus D68 in pediatric sera collected in a community before, during, and after a possible outbreak.

Francois Marie Ngako Kadji1,2, Hidekazu Nishimura1, Michiko Okamoto2, Ko Sato1, Suguru Ohmiya1, Hiroko Ito1, Akira Suzuki1,2,3, Yukio Nagai4, Hitoshi Oshitani2.   

Abstract

Previously, we reported a hospital-based epidemiological study on enterovirus (EV)-D68 infection among children during the autumn of 2015, which indirectly inferred an outbreak in Sendai, Japan. In the present study, we collected sera from children (aged 0-6 years; without symptoms of infectious diseases) in the Sendai community during four sample collection periods (1 year before, 6 months before, immediately after, and 1 year after the possible outbreak period). Immunity levels against EV-D68 infection in the children were analyzed by assaying the neutralization antibody titers of the sera. Further, it was confirmed that the immunity levels considerably increased during the possible outbreak period and gradually waned over 1 year in the absence of another outbreak. These results provide background information that supports the results of our previous hospital-based surveillance.

Entities:  

Keywords:  Enterovirus D68; Neutralizing antibody; children; seroprevalence

Year:  2019        PMID: 31474700     DOI: 10.7883/yoken.JJID.2019.056

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  2 in total

1.  Neutralizing Enterovirus D68 Antibodies in Children after 2014 Outbreak, Kansas City, Missouri, USA.

Authors:  Robyn A Livingston; Christopher J Harrison; Rangaraj Selvarangan
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

2.  Enterovirus D68 seroepidemiology in Taiwan, a cross sectional study from 2017.

Authors:  Jian-Te Lee; Wei-Liang Shih; Ting-Yu Yen; Ai-Ling Cheng; Chun-Yi Lu; Luan-Yin Chang; Li-Min Huang
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.